Venlax ER 37.5 mg

Venlax ER 37.5 mg is a medicine authorised by Swissmedic under authorisation number 59106. The authorisation holder is Drossapharm AG. The medicinal product code is Synthetic medicines and the dispensing category is B: Supplied only against a prescription which, at the prescriber's discretion, may be dispensed repeatedly. First authorisation was granted on 04 June 2009 and the authorisation is valid without a time limit. ATC code N06AX16 places the medicine in the group Psychoanaleptics.

  • Dispensing category B
  • Authorisation number 59106
  • ATC N06AX16
  • Synthetic medicines
Authorisation data
Authorisation number59106
NameVenlax ER 37.5 mg
Full nameVenlax ER 37.5 mg, Hartkapseln, retardiert
Authorisation holderDrossapharm AG
Medicinal product codeSynthetic medicines
Dispensing categoryB · Prescription only
ATC codeN06AX16
First authorisation04 June 2009
Authorisation validityunlimited
Strengths
No.NameDispensing categoryAuthorisation date
1Venlax ER 37.5 mg, Hartkapseln, retardiertB27 May 2010
2Venlax ER 75 mg, Hartkapseln, retardiertB04 June 2009
3Venlax ER 150 mg, Hartkapseln, retardiertB04 June 2009

Scroll the table sideways

Pack sizes
Pack codeQuantityUnitATCIT codeDispensing category
77Kapsel(n)N06AX1601.06.0.B
114Kapsel(n)N06AX1601.06.0.B
228Kapsel(n)N06AX1601.06.0.B
398Kapsel(n)N06AX1601.06.0.B
414Kapsel(n)N06AX1601.06.0.B
528Kapsel(n)N06AX1601.06.0.B
698Kapsel(n)N06AX1601.06.0.B

Scroll the table sideways

Medicines in the same ATC group

Other medicines from this authorisation holder

Frequently asked questions

Is Venlax ER 37.5 mg authorised in Switzerland?

Yes. Venlax ER 37.5 mg is authorised by Swissmedic under authorisation number 59106, data as of 01 September 2026. The authorisation is valid without a time limit.

Which dispensing category does Venlax ER 37.5 mg have?

Venlax ER 37.5 mg is in dispensing category B. Supplied only against a prescription which, at the prescriber's discretion, may be dispensed repeatedly.

Who is the authorisation holder of Venlax ER 37.5 mg?

The authorisation holder is Drossapharm AG. The holder carries the legal responsibility for quality, safety and product information of the medicine in Switzerland.

Sources

Swissmedic data as of 01 September 2026. No medical advice. Independent directory, not affiliated with Swissmedic or the FOPH.

Authorisation in Switzerland?

About 2 minutes. No obligation.

First, a little about your business.

Your answers stay in this page until you send your enquiry.

What would you like to achieve?

Your project

Where can we reach you?

You can go back to review your answers before sending.

* Required fields
Prefer email? info@swissmedicinesdirectory.com